Conferences and Meetings on Pharmacology and Drug Development

Conference-Service.com offers, as part of our business activities, a directory of upcoming scientific and technical meetings. The calendar is published for the convenience of conference participants and we strive to support conference organisers who need to publish their upcoming events. Although great care is being taken to ensure the correctness of all entries, we cannot accept any liability that may arise from the presence, absence or incorrectness of any particular information on this website. Always check with the meeting organiser before making arrangements to participate in an event!

Meeting organisers can submit meetings free of charge for inclusion into the listing.

ALL COUNTRIES

1.
 
CMS3 — Advanced Topics on Cell Model Systems
ID
789585
Dates
20 Jun 2016 - 24 Jun 2016
Location
Rome, Italy
Abstract
An intensive one week laboratory and lecturer school for PhD students and young researchers in the Eternal City Rome to facilitate an effective sharing and dissemination of new and innovative research ideas, strategies, focal points on cell model systems to promote pharmaceutical, pharmacogenomics, tissue engineering and computational research together with twelve outstanding scientists from different countries: Germany, Israel, Italy, Switzerland, United Kingdom. Fiftheen scientists of the Research Establishment of National Research Council (CNR) will impart practical exercises at laboratories on techniques in model membrane systems, optical microscopy, Raman and IR spectroscopy, nanostructures and biosensors, and dynamic molecular simulation. No other schools are present in Europe on this specific topic and mixing of theoretical and practical approaches.The school is certified as UNI EN ISO 9001:2000. The management respects the standard procedure and quality of international level. Participants must have a degree in either: Physics, Mathematics, Chemistry, Engineering, Biology or Medicine and a basic working knowledge of experimental research. Preference will be given to Ph.D. students and junior scientists under 35 and to those having not more then five years research experience. Applicants should send their current CV to the School Secretariat by email to: cms3.cnr@gmail.com , together with a formal signed letter of recommendation from a Professor who is aware of their work. The CV should include details of academic qualifications and a list of scientific publications as well as a short description of their current scientific research. Closing date for applications: May 6th, 2016. Registration fee:150 eur per person. It includes all academic sessions, course material, daily coffee-break and lunch (without drinks), social programme and certificate of completation.
Contact
Alfonsina Ramundo Orlando;     Phone: [+39 (0)6 45488213];     Email: cms3.cnr@gmail.com
Topics
Cell model systems, Biophysics, Pharmacology, Imaging, Bio-sensors, Molecular Dynamic Simulations
Related subject(s)
Event website
2.
 
Minnesota NMR Center 4th Annual Advanced Protein Workshop
ID
810480
Dates
20 Jun 2016 - 24 Jun 2016
Location
Minneapolis, MN, United States
Abstract
This summer, the Minnesota NMR Center will offer once again, the annual "hands on" advanced NMR workshop, in which attendees will have the opportunity to learn methods applicable to both soluble and membrane-bound proteins. Not only will graduate students and postdoctoral associates familiarize themselves with state-of-the-art multidimensional techniques in solution NMR spectroscopy, but they will also be given an introduction to solid-state NMR methods and an opportunity to apply them to membrane-bound proteins.
Topics
NMR, NMR Spectroscopy, Workshop, Conference, solid-state, solution, membrane, protein, spectra, structure, biology, chemistry, physical, Minnesota, TopSpin, VNMRJ, nmrPipe, Sparky, Rosetta, sequential assignments, structure analysis, protein dynamics.
3.
 
Virus-Like Particle & Nano-Particle Vaccines VLPNPV 2016
ID
759990
Dates
22 Jun 2016 - 24 Jun 2016
Location
Leiden, Netherlands
Abstract
Virus-like particles are supra-molecular assemblages incorporating key immunologic features of viruses which include repetitive surfaces, particulate structures with potential for induction of innate immunity through activation of pathogen-associated molecular-pattern recognition receptors. They carry no replicative genetic information and can be produced in heterologous expression systems at large scale. Virus-like particles thus represent a safe and effective vaccine platform with potential to induce potent B- and T-cell responses. In addition to being effective vaccines against the corresponding viruses from which they are derived, virus-like particles can also be used to present foreign epitopes to the immune system. This can be achieved by genetic fusion or chemical conjugation. This technological innovation has greatly broadened the scope of their use, from immunizing against microbial pathogens to immunotherapy for chronic diseases. Towards this end, virus-like particles have been used to induce auto-antibodies to disease-associated self-molecules involved in chronic diseases, such as hypertension and Alzheimer’s disease. The recognition of the potent immunogenicity and commercial potential for virus-like particles has greatly accelerated research and development activities. During the last decade, two prophylactic virus-like particle vaccines have been registered for human use, while another 12 vaccines entered clinical development. VLPNPV 2016 is the third meeting in this new series for international researchers working on Virus-Like Particles (VLPs) and Nano-Particle Vaccines (NPVs).
4.
 
FDA’s GMP Expectations for Phase I and First-in-Man Clinical Trials
ID
806252
Dates
23 Jun 2016 - 24 Jun 2016
Location
Boston, United States
Abstract
Manufacturing an investigational product for the initial pilot clinical trials could pose a considerable logistical and financial challenge to developers. The first-in-man and pilot clinical trials are usually conducted in very small number of healthy participants with lower doses primarily to establish safety and hence do not need a significant amount of investigational material. The US FDA allows developers to test early stage investigational products under relaxed GMP requirements. The manufacturing requirements for early stage clinical trials are designed to assure adequate quality of the investigational product being tested without the excessive regulatory burden of full-scale GMP manufacturing. This workshop will present the current regulations, guidance documents and regulatory strategies available for manufacturing an early development stage product for Phase I and first-in-man clinical trials. Also discussed will be logistical issues with managing the supply of an early stage investigational product, and requirements for stability testing, storage and shipping, labeling, and documentations. Perspectives for different classes of products will be presented using case studies.
Contact
Peter Brown;     Phone: [+1 410-501-5777];     Email: pbrown@fdamap.com
Topics
FDA GMP Regulations, FDA GMP Guidance, GMP for Phase 1, Good Manufacturing Practices, Phase 1 in Clinical Trials, Clinical Trials Regulations, Raw Materials Management
5.
 
Understanding the Statistical Considerations for Quantitative ICH Guidelines
ID
810995
Dates
23 Jun 2016 - 24 Jun 2016
Location
San Francisco, United States
Abstract
This course is designed to introduce to individuals the understanding and interpretation of the statistical concepts with reference to certain quantitative ICH Guidelines that apply across laboratory (drug development) and clinical development (drug/device) procedures such as analytical methods in validation and acceptance criteria in calibration procedures, risk management and process monitoring as well as dealing with uncertainties and other relevant issues. It is not a course in statistics but introduces the participant to a hands on approach to the statistical techniques one uses, how they are applied and reasonably interpreted and understood. One will address the various challenges facing pharmaceutical and biotechnology companies when it comes to quantifying results in a meaningful interpretable manner through tabulations and graphical presentations.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
Statistical considerations for quantitative ich guidelines training, quantitative measurement procedures, sensitivity of the sample size
6.
 
Designing and Sustaining New and Existing Product Stability Testing Program
ID
811038
Dates
23 Jun 2016 - 24 Jun 2016
Location
San Francisco, United States
Abstract
New or existing modified drug Stability Testing Program's regulations/requirements stipulated by the FDA, 21 CFR or other regulations may sometimes creating an overwhelming situation based on the type of product that is being manufactured. Hence, some manufacturers of new drug products have made inadvertent mistakes in the design of their new drug stability testing program. Such mistakes may ultimately delay the new, existing or modified product IND or NDA application process due to the data that was presented to the FDA (i.e. Relevant aspects of the stability testing program requirement may have been omitted by the drug manufacturers). It is better to understand, follow and apply the full requirements of a new product stability testing requirement from the onset or to correct an existing stability testing program so as to avoid future pitfalls and delayed IND or NDA submission process by the FDA. Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
FDA's Drug Stability Testing Program, NDA submission, 21CFR 514.1(b)(5)(x) expectations, Analytical Testing Considerations
7.
 
Lyophilisation Europe
ID
799435
Dates
04 Jul 2016 - 05 Jul 2016
Location
London, United Kingdom
Abstract
SMi is thrilled to announce the return of its 4th annual conference, Lyophilisation Europe, taking place on 4th and 5th July in London, UK. With the rising risk of contamination and the need for improved formulation methods of biological products, robust capabilities in lyophilisation and freeze drying methods have become critical for process efficiency and commercial success whilst maintaining drug quality and stability. Innovation and efficiency is requested at every level making Lyophilisation Europe 2016, the perfect platform to strengthen knowledge in key principles such as PAT and QbD, whilst staying at the forefront of technological breakthroughs to adapt to a competitive growing industry.
Contact
Teri Arri;     Phone: [+442078276000];     Email: tarri@smi-online.co.uk
Topics
lyophilisation, quality by design, freeze drying, scale-up, validation, spray drying, Process Analytical Techniques, PAT, robustness, stability, delivery, optimisation, protein stabilisation, design strategies, maintenance, automatic loading and unloading, lyophilization, qbd, protein, optimization, aseptic, fill/finish, temperature, drying, powder, nucleation, sterilization, injectables, thaw, storage, crystallization, formulation, parenteral, lyophilization
8.
 
Pharmaceutical Supply Chain Integrity - Good Distribution Practices (GDP)
ID
810981
Dates
04 Jul 2016 - 05 Jul 2016
Location
Shanghai, United States
Abstract
In China's latest public health scandal over the alleged illegal distribution of improperly stored vaccines that has reignited drug-safety concerns in China. According to state media, vaccines valued at almost $90 million have been distributed across the country. The health regulator says the vaccines were all produced by licensed manufacturers, but were stored and transported without proper refrigeration.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
Good Distribution Practice, GDP with GMP, supply chain, risk management, PIC/S, GDP (GWP) regulations, GSP, GWP
9.
 
Allergies
ID
808714
Dates
06 Jul 2016 - 07 Jul 2016
Location
London, United Kingdom
Abstract
Created with a top panel of industry thought leaders, SMi’s 3rd annual Allergies show returns to London on 6-7 July 2016, to capture expert insights by honing in on new pathways with novel vaccines and adjuvants, immunoassays for molecular diagnostics, paediatric allergies, personalised treatment, allergen specific immunotherapies, plus much more. Through strategic direction and regulatory guidance, the programme will strengthen knowledge in topics such as biomarker validation, and arm attendees with the key requirements and tools for successful trials and study outcomes. Featured speakers include: MHRA, Stallergenes Greer, HAL Allergy, Inflamax Research Inc , Allergy Therapeutics, Danone, Nestle, Nippon Medical School + many more! For details visit www.allergies-event.com
Contact
Teri Arri;     Phone: [+442078276000];     Email: tarri@smi-online.co.uk
Topics
Allergy, Desensetisation, monoclonal antibody, vaccines, adjuvants, asthma, Pediatric, Paediatric, allergenoids, SLIT, SCIT, Dermatitus, policy, pathways, immunoglobulin, allergen, airway, reaction, allergic, clinical trials, immunotherapy, mite, food allergy, rhinitis, allergoid, respiratory, inflammation, dermatology, rash, dust mites, steroid, seroepidemilogical, biomark, vaccine, adjuvant, allergic disease, peanut allergy, milk allergy, diagnostic, pollution
Related subject(s)
10.
 
RICT 2016 — Interfacing Chemical Biology and Drug Discovery
ID
788756
Dates
06 Jul 2016 - 09 Jul 2016
Location
Caen, France
Event website
11.
 
Asia-Pacific Pharma Congress
ID
726968
Dates
14 Jul 2016 - 16 Jul 2016
Location
Kuala Lumpur, Malaysia
Abstract
Asia Pharma-2016 is supported with related journals and their editorial board members which provide a chance of meeting them, along with experts in Medicine, Pharmacological sciences and Pharmaceutical sciences.Asia Pharma-2016 will be a great event where experts from universities, top Pharmaceutical industries, research centers and from the societies and association related to Pharmaceuticals. So, all are whole heartedly invited to be a part of this conference.
Contact
Robert Brown;     Phone: [1-650-268-9744];     Email: asiapharma@pharmaceuticalconferences.com
Topics
IPR and Regulatory Affairs, Pharmacognosy, Pharmaceutics, Nanotechnology, Industrial Pharmacy, Pharmacology, Pharmaceutical Chemistry, Pharmaceutical Analysis, Pharmaceutical Microbiology, Pharmaceutical Biotechnology, Biochemistry, Hospital and Clinical Pharmacy.
12.
 
FASEB SRC: Translational Neuroimmunology: From Mechanisms to Therapeutics
ID
786126
Dates
24 Jul 2016 - 29 Jul 2016
Location
Big Sky, Montana, United States
Abstract
This FASEB Science Research Conference will bring a greater understanding of the biochemical and molecular mechanisms underlying diseases associated with dysfunction in the neuroimmune system will undoubtedly facilitate the translational aspect of this field as novel therapeutic targets are moved towards human clinical trials. This will be facilitated by cutting-edge talks from scientists with international reputations on the topics of 1) CNS Metabolism and the Microbiome; 2) Inflammation in the Peripheral Nervous System; 3) Stem Cells and Neuroinflammation; 4) Neuroinflammatory Mechanisms of Demyelinating Diseases; 5) Immunity and Neurodegenerative Diseases; 6) Pre-clinical Studies for CNS Neuroinflammatory Diseases; 7) Neuroinflammation and Neurotrauma; 8) Neuroinflammation and Host Defense; and 9) The Many Faces of Microglia. In addition, this SRC will host a pre-meeting workshop entitled
Contact
FASEB SRC Staff;     Phone: [3016347010];     Email: SRC@faseb.org
Related subject(s)
13.
 
3rd Annual Advanced API Convention
ID
799333
Dates
25 Jul 2016 - 27 Jul 2016
Location
Mumbai, India
Abstract
The 3rd Annual Advanced API Convention will be held in Mumbai between 25 – 27 July 2016. Intended as the foremost event for the API industry in India, the Advanced API Convention 2016 is an exciting event bringing the scientists of the world, Industry experts and key stakeholders under one platform. The Indian API market stands third in the world. At the same time, it relies heavily on China. This is a serious matter of concern which needs to be addressed to reduce dependency on China. CPhI always strives to voice out the concerns of Pharma professionals, and this year again we are delighted to bring you the 3rd Annual Advanced API Convention with an idea to encourage production of quality API’s, tackling problems right from R&D to Manufacturing phase.
Contact
Drashti Shah;     Phone: [+91-22-61727381];     Email: drashti.shah@ubm.com
Topics
API, Convention, Conferences on API, QbD, Data Integrity, Scale-up, R & D, Elemental Impurities, Genotoxic impurities DoE, PAT, Q11, QRM, risk assessment, particle engineering, ICH Q8, ICH Q9, API Convention, API development, Flow chemistry, green chemistry, polymorph, crystallization, quality and yield, process design, equipment design, control strategy, GMP, CAPA, micronization, CQA’s, purifying, recrystallization, ICH M7, regulatory, process development, method development, impurities, manufacturing, implementation, quantitative distribution, consistent, design space, modelling tools, crystal size, distribution, Data Integrity
14.
 
CSDD-2016 — II International Conference on Clinical Sciences and Drug Discovery
ID
790723
Dates
27 Jul 2016 - 29 Jul 2016
Location
Dundee, Scotland, United Kingdom
Abstract
United Scientific group had successfully completed its first conference International conference on Clinical Sciences and Drug Discovery, in Baltimore USA, during November 02-04, 2015 (CSDD-2015). With this enthusiasm and prodigious success, we are proudly announcing the second conference International conference on Clinical Sciences and Drug Discovery -2016, Dundee, Scotland during July 27-29, 2016 (CSDD-2016) with a theme Drug discovery and development to clinical trials. Our focus lies on the translation of academic research findings into industry-driven drug development, Features including a world-class program of invited speakers from industry and academia, oral and poster presentations from submitted abstracts maintaining the same level of talks. Throughout the course of the three-day conference, you will get an exclusive opportunity to network and be involved in inspiring and interesting discussions of scientists and researchers on Antimicrobials: Bacterial, Fungal, Viral, Protozoal, Antineoplastic, Endocrinology and Metabolism, Hematological, CNS & ANS, Cardio-Vascular System, Respiratory, Nano therapeutics, Computer Aided Drug Designing, Structural Biology and many more research topics. The organizing committee is confident that participants will benefit from the high value scientific program. We welcome all the researchers to join us for these 3 days of stimulating discussions, knowledge sharing and networking event.
Contact
CSDD-2016 Committee;     Phone: [408-426-4833];     Email: drugdiscovery@uniscigroup.org
Topics
Infectious: Bacteria, Fungi, Viruses, Protozoa, Neoplastic: Cancers, Tumours, and Lymphomas, Endocrinologic and Metabolic, Hematological, CNS & ANS, Cardiovascular, Respiratory, Immunological, Nano-Bio Therapeutics, Computer Aided Drug Design, Structural Biology, Medicinal Chemistry & Imaging
15.
 
Innovations in Formulation and Drug Delivery 2016
ID
809460
Dates
28 Jul 2016 - 29 Jul 2016
Location
Mumbai, India
Abstract
Of the total number of pharmaceutical manufacturers functioning in India, about 77% produce formulations and the remaining are into bulk drugs. At the same time, it is important for these manufacturers to produce quality drugs by complying with the regulatory authority guidelines. Considering this, CPhI brings you Innovations in Formulation and Drug Delivery, a two day event focused on improving drug performance and therapeutic impact through enabled formulations and more effective delivery methods
Contact
Sean Palanna;     Phone: [91 22 6172 7072];     Email: sean.palanna@ubm.com
16.
 
IDDW — International Drug Development Workshop
ID
820480
Start date
06 Aug 2016
Location
Kuala lumpur, Malaysia
Contact
Liew Kai Bin;     Phone: [+60 174695260];     Email: secretariat_iddw2016@ucsiuniversity.edu.my or liewkb@ucsiuniversity.edu.my.
Topics
A. Plenary lectures The Quest for New Medicines: Issues & Challenges by Prof Dr Sreeharan: This lecture will shed light on several issues that have surfaced in recent times to challenge the current R&D model of drug discovery and development. Declining R&D productivity, safety concerns involving some of the new classes of medicines and the lack of progress on medicines for the “developing world” are some of the issues and approaches to overcome will be discussed. Drug Discovery and Development: Potential of Herbal Medicine for Resistant Cancer Chemotherapy by Prof Dr Moses Chow: The role of herbal medicines which usually contains multiple components some of which can possess anticancer properties capable of targeting multiple mechanisms will be discussed. The preclinical and clinical studies needed to demonstrate the effectiveness of herbal medicines will also be discussed. Pharmaceutical Medicine: Regulations, Medical Governance and Commercialisation by Dr Sam Lim: This lecture will speak about the various regulations that governs the development of medicines. This will include the regulatory environment and the conduct of clinical trials, the commercialisation of a medicine post approval including life cycle management, code of conduct and pharmacovigilance. B. Interactive discussion workshop A Case Study on Development of Herbal Medicine from Plant X Pre-clinical studies, clinical studies and quality control of the product of herbal medicine from traditional plant will be discussed in this workshop. A Case Study on Development of a Monoclonal Antibody for Severe Asthma Key development, commercial issues, clinical plan, clinical studies required for a positive regulatory approval, and activities required for successful commercialisation of the monoclonal antibody product for severe asthma will be discussed and the solutions to the problems expected to be faced will be explored.
17.
 
7th Annual Global Pharma Summit
ID
803057
Dates
22 Aug 2016 - 24 Aug 2016
Location
New Orleans, United States
Abstract
Pharma-2016 is a global conclave to discuss and learn about the sessions viz., Pharmaceutical Preformulation, Novel Drug Delivery Systems, Pharma Nanotechnology, Clinical Pharmacy, Pharmacology and Toxicology, Pharmacognosy and Phytochemistry, Pharmacy Practice, Medicinal Chemistry, Industrial Pharmacy, Regulatory Authorities, Bio and Chemo informatics, Market analysis and Business Opportunity.
18.
 
Drug Discovery & Therapy World Congress 2016 (4th in the Series)
ID
797134
Dates
22 Aug 2016 - 25 Aug 2016
Location
Boston, MA, United States
Abstract
This unique international conference will provide a platform for all pharmaceutical scientists, internists and primary care physicians to discuss important international breakthroughs in drug discovery and new therapeutics. The focus of the conference will be on the interdisciplinary fields of drug discovery, drug therapy and translational medicine.
Contact
Hasina Habib;     Phone: [+1-857-2398855];     Email: hasinahabib@eurekaconference.com
Topics
Academic CRO/Industrial collaborations in drug discovery Anti-Infectives Bioactive Lipids Biologics Clinical Trials and Regulatory Affairs Cancer Targeted Drug Delivery Cardiovascular Drug Discovery & Therapy Chemistry Combinatorial Chemistry CNS Drug Discovery & Therapy Diabetes and Obesity Drug Discovery & Therapy Drug Delivery & Targeting Drug Discovery in Preclinical Research Drug Metabolism Enabling Technologies Genomics Green Techniques for Medicinal Chemistry High-throughput Screening & Laboratory automation Hot Topics in Drug Targets Hot Topics in HIV Research Hot Topics in Medicinal Chemistry Hot Topics in Natural Products Inflammation and Immunology Innovative Drug Discovery and Nanotechnology In-silico Drug Design and in-silico screening Medical Imaging Nutraceutical Drug Discovery & Therapy Pharmaceutical Biotechnology Pharmaceutical Research & Development Pharmacogenomics Process Chemistry and Drug Manufacturing Protein and Peptide Sciences Proteomics & Bioinformatics Pulmonary Drug Discovery & Therapy Recent Advances in Patient Treatment and Care Recent Advances in Spectroscopy Regenerative Medicine Stereoselective Synthesis of Bioactive Compounds Structural Biology Systems Biology in Drug Design Traditional Chinese Medicine Translational Medicine Women’s Health Drug Discovery & Therapy
Event website
19.
 
Biosimilars Congress India 2016
ID
818031
Dates
01 Sep 2016 - 02 Sep 2016
Location
Hyderabad, India
Contact
Drashti Shah;     Email: drashti.shah@ubm.com
Topics
Regulatory expectations for Biosimilars in US, EU and Japan, Updates on the recent CDSCO Guidelines released on 26th March 2016, Domestic food-beverage manufacturers and suppliers, Identifying critical quality attributes of innovator reference products, Statistical analysis to determine biosimilarity, Assessing the Quality and CMC consideration for biosimilars
20.
 
10th Vaccine Congress
ID
800469
Dates
04 Sep 2016 - 07 Sep 2016
Location
Amsterdam, Netherlands
21.
 
IIR-cryobio-workshop — IIR Workshop on Cold Applications in Life Sciences
ID
789087
Dates
08 Sep 2016 - 09 Sep 2016
Location
Dresden, Germany
Abstract
Cell/tissue cryopreservation and cold storage are central challenges e.g. in biobanking. Freezing and cryoprocessing are becoming increasingly important as an essential production step in life sciences, too.
Contact
Dr. Gabriele Spoerl;     Phone: [+49 351 4081 604];     Email: gabriele.spoerl@ilkdresden.de; CryoWorkshop2016@ilkdresden.de
Topics
Cell/tissue cryopreservation and storage challenges: advanced devices for cryopreservation and freeze-drying, cryobanking of biologicals, 3D-scaffolds / tissue engineering for medical and diagnostic applications, strategies with alternative cryoprotectants for tissues cryopreservation, industrial solutions in biomaterial processing. Freezing and storage of active agents for in-vitro and in-vivo applications: damage processes on active agents caused by cold application, process limitations and impact factors on product stability, process validation – analytics, monitoring and simulation of process and product loss, vitrification of cellular products without cryoprotectants, industrial freezing solutions - large scale and multi-product plant.
Related subject(s)
22.
 
11th Drug Design & Medicinal Chemistry Conference
ID
806716
Dates
12 Sep 2016 - 13 Sep 2016
Location
Boston, United States
Abstract
We invite you to attend the 11th Drug Design & Medicinal Chemistry Conference, which will take place September 12-13, 2016 in Boston, MA. This meeting will provide a forum for scientists across multiple disciplines, from both industry and academia, to connect and share complementary perspectives. We will discuss emerging target classes, advances in antibody drug conjugates and other methods for targeted drug delivery, new approaches in flow chemistry, and much more. In addition to scientific presentations, we will have dedicated times for networking among delegates.
Contact
Kristen Starkey;     Phone: [6262566405];     Email: infogtcbio@gtcbio.com
Topics
Drug Design, Medicinal Chemistry
23.
 
2016 Pharma CI USA Conference & Exhibition
ID
807082
Dates
13 Sep 2016 - 14 Sep 2016
Location
Parsippany, NJ, United States
Abstract
The Best and Largest Assembly of Pharmaceutical Competitive Intelligence Executives! The 2016 Pharma CI USA Conference & Exhibition (Sept. 13-14, 2016, Parsippany, NJ) is the industry's gold standard for senior level pharma, biotech, and medical device professionals who seek the latest in competitive and business intelligence.
Contact
Ross Frasier;     Email: ross@pharmaciconference.com
Topics
pharma, pharmaceutical, biopharma, competitive intelligence, business intelligence
24.
 
BPA — BioPharm America™ 2016—9th Annual International Partnering Conference
ID
795837
Dates
13 Sep 2016 - 15 Sep 2016
Location
Boston, United States
Abstract
Beginning its ninth year as an industry event, BioPharm America™ creates a robust exchange among hundreds of executives from venture capital firms, major pharmaceutical companies, academic institutions and biotechnology companies of every size from mature to startup. The event brings dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development.
Topics
partnering, business development, biotech, pharmaceutical, medical device, diagnostic, licensing, finance
25.
 
BEU — BIO-Europe® 2016 - 22nd Annual International Partnering Conference
ID
820016
Dates
13 Sep 2016 - 15 Sep 2016
Location
Boston, United States
Abstract
The 22nd annual BIO-Europe® event is the largest biotechnology partnering conference held in Europe. Over 3,500 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. Business development executives and dealmakers consider BIO-Europe a must-attend event and an effective business strategy enabling them to meet and present to numerous potential partners. BIO-Europe features the industry’s most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward.
Contact
Camille Del Carmen;     Phone: [+1 760 930 0500];     Email: cdelcarmen@ebdgroup.com
Topics
partnering, business development, biotech, pharmaceutical, medical device, diagnostic, licensing, finance, life science
Related subject(s)
26.
 
4th GPCR in Drug Discovery Conference
ID
812619
Dates
14 Sep 2016 - 15 Sep 2016
Location
Boston, United States
Abstract
We invite you to attend the 4th GPCR in Drug Discovery Conference, which will take place September 14-15, 2016 in Boston, MA. G protein-coupled receptors are the largest family of protein receptors and account for one of the largest classes for drug targets currently in the market. Continued breakthrough and insights into the structural biology of GPCRs have opened up greater potential of this target class to impact drug discovery and renewed interest in this field.
Contact
Kristen Starkey;     Phone: [6262566405];     Email: infogtcbio@gtcbio.com
Related subject(s)
27.
 
MUCOVAD 2016 — Mucosal Vaccines, Adjuvants & Delivery
ID
762155
Dates
14 Sep 2016 - 16 Sep 2016
Location
Lausanne, Switzerland
Abstract
MUCOVAD 2016 will be an opportunity for researchers to hear updates on new developments in the area of mucosal vaccines and associated adjuvantation and delivery mechanisms/platforms
28.
 
4th Antivirals Congress
ID
801122
Dates
18 Sep 2016 - 21 Sep 2016
Location
Barcelona - Sitges, Spain
Abstract
The key objectives of these unique interdisciplinary conferences are:  To enable researchers from around the world to present important new findings;,  To highlight recent advances in drug and vaccine development, from basic science through clinical trials,  To publicize novel techniques that will speed the pace of research;,  To facilitate interdisciplinary collaborations, by providing opportunities for networking among laboratory scientists, clinicians and public health officials.. Meeting sessions will focus on new antiviral drugs, novel approaches to preventive and therapeutic vaccines, structural studies of viral proteins, antiviral drug resistance, emerging viruses and other topics.  The Congresses are sponsored by Antiviral Research, a journal for research on the prevention and treatment of viral diseases, now in its 35th year of publication. 
Related subject(s)
29.
 
DOT — 14th Annual Discovery on Target
ID
806859
Dates
19 Sep 2016 - 22 Sep 2016
Location
Boston, MA, United States
Abstract
Cambridge Healthtech Institute will host the 14th Annual Discovery on Target event this September 19-22, 2016 in Boston, MA. Spanning four days, the event showcases current and emerging “hot” targets for the pharmaceutical industry. Over 1,100+ attendees (from 26 countries) composed of scientists/technologists, executives, directors, and managers from biopharma, academic, and healthcare organizations participate annually. The 2016 event is comprised of 17 conference tracks, 1 training seminar, 5 symposia, 16 short courses, an exhibit hall of 50+ companies, 135+ posters, and dedicated networking sessions. Discovery on Target assembles an impressive group of 300+ distinguished speakers who look forward to sharing their knowledge, best practices, and expertise with all attendees.
Contact
Phone: [7819725400];     Email: chi@healthtech.com
Topics
drug discovery, drug development, pharma, diseases, genomics, cancer
Related subject(s)
30.
 
EYE — 4th Annual Targeting Ocular Disorders
ID
806869
Dates
20 Sep 2016 - 21 Sep 2016
Location
Boston, MA, United States
Abstract
With its complex structure and the breadth of ocular disorders, the eye presents unique challenges to drug discovery. Cambridge Healthtech Institute’s fourth annual Targeting Ocular Disorders conference provides a platform to discuss novel targets and disease pathways, the latest drug delivery methods, and the most promising emerging therapies. A special focus will be on gene therapy, stem cell therapies, and treatments outside of the well-established anti-VEGF therapies. The event will cover a broad range of diseases including but not limited to glaucoma, wet and dry age‐related and diabetic macular degeneration, retinopathy and retinitis pigmentosa.
Contact
Phone: [7819725400];     Email: chi@healthtech.com
Topics
ophthalmology, retinal diseases, gene therapy, ocular disorders, drug delivery, stem cells
Related subject(s)
31.
 
ABK — PEGS Korea 2016: The Essential Protein Engineering Summit
ID
806802
Dates
20 Sep 2016 - 22 Sep 2016
Location
Seoul, South Korea
Abstract
From the earlier regulatory successes of Adcetris® and Kadcyla® to the recent FDA approval of Blincyto®, to the current clinical successes of Opdivo® and Keytruda®, the industry is abuzz with excitement and new hope. The successes of antibody-drug conjugates, bispecific antibodies and immunotherapy drugs and combinations are opening new doors for biotech companies to discover and develop breakthrough remedies.
Contact
Phone: [7819725400];     Email: chi@healthtech.com
Topics
protein engineering, antibody engineering, cancer immunotherapy
32.
 
Cell & Gene Therapy Europe
ID
820692
Dates
21 Sep 2016 - 22 Sep 2016
Location
Berlin, Germany
Abstract
Be part of the only cell and gene therapy event to offer commercial, regulatory, supply chain and R&D insight to ensure next-generation ATMP success. Phacilitate have assembled a unique speaker list that brings together all the key voices in the cell and gene therapy sector including Big Pharma, biotech, VCs, HTAs, payers and regulators.
Contact
Carina Hunter;     Phone: [+44(0)2073847897];     Email: team@phacilitate.co.uk
Topics
gene therapy, regulatory, supply chain, R&D, ATMP, cell biology
33.
 
Immunotherapy Europe
ID
820779
Dates
21 Sep 2016 - 22 Sep 2016
Location
Berlin, Germany
Abstract
Be part of the only immuno-oncology event to combine business, R&D, partnering and regulatory sessions to give attendees the vital big picture. Phacilitate have assembled a unique speaker panel with a holistic approach to covering oncology combination immunotherapy strategy development. Hear from all the key stakeholders within the immuno-oncology space including Big Pharma, biotech, payers, HTAs, regulators and leading investors. Co-located alongside Cell & Gene Therapy Europe, join 350+ senior executives from across the cell, gene and immunotherapy space. With 77% Director-level and above, this is the place to meet new partners and collaborators to achieve next-generation immuno-oncology success.
Contact
Carina Hunter;     Phone: [+44(0)2073847897];     Email: team@phacilitate.co.uk
Topics
immunotherapy, oncology, regulatory session, cancer research, big pharma, biotech, payers, HTAs, regulators, leading investors
34.
 
Cancer Vaccines
ID
809596
Dates
21 Sep 2016 - 22 Sep 2016
Location
London, United Kingdom
Abstract
Aimed at an audience of senior scientists and oncology specialists involved in targeted vaccines and drug research, Cancer Vaccines 2016 will provide a perfect platform to discuss pioneering clinical developments and the next generation of cancer immunotherapy. The 5th annual show will capture expert insight by honing in on new pathways with novel vaccines and immunotherapies, drug formulations, personalised treatment, immune check-point inhibitors, plus more
Contact
Teri Arri;     Phone: [+442078276000];     Email: tarri@smi-online.co.uk
Topics
Cancer vaccines; combination cancer immunotherapy; CAR, T-Cell; Dendritic Cells; Epitopes, Cancer, vaccine, combination therapies, adjuvants, chimeric antigen receptors, cells, immunotherapies, tumour, efficacy, delivery, therapeutic vaccines, immune monitoring, PDL-1, CTLA4, monoclonal antibodies, conference, London; tumour, immune, genetic heterogeneity, angiogenic, immune-oncology, oncology, rna, immunogen, immune, personalized therapy, protein, biomarker, disease, novel pathway, molecular, vaccinology, cell-based, liposomes, dna, peptide, vaccine
Related subject(s)
35.
 
12th Annual Quality in Pharma & Biotech
ID
811795
Dates
22 Sep 2016 - 23 Sep 2016
Location
Vienna, Austria
Abstract
This event will exploit the importance of shifting from a culture of compliance to a culture of quality and improvement. Get updated on FDA- /EMA hot topics and how they are implemented by the industry. Explore how to make your processes more efficient and achieve a lean & cost-passive QA and QC.
Contact
Andrea Weber;     Phone: [+421 257 272 145];     Email: andrea.weber@fleming.events
Topics
Culture of quality & change management, Lean quality, Quality metrics, GMP inspection observations, warning letters and consent decrees, ISO IDMP, Critical quality considerations for serialization, Data integrity, CMO quality oversight, Quality risk management, Technology transfer
Event website
36.
 
SIPCD 2016 — 4th Symposium on Innovative Polymers for Controlled Delivery
ID
800428
Dates
23 Sep 2016 - 26 Sep 2016
Location
Suzhou, China
Event website
37.
 
Chemical biology approaches to assessing and modulating mitochondria
ID
776810
Dates
26 Sep 2016 - 27 Sep 2016
Location
The Royal Society at Chicheley Hall, Buckinghamshi, United Kingdom
Abstract
Mitochondria are central to many current biomedical problems. In these, variations in chemical processes are critical, but progress in understanding these and in developing therapies has been hampered by lack of methods to measure and manipulate mitochondrial 'chemistry'. This meeting will explore the interface of chemical biology and mitochondrial studies to open up new avenues for research and therapeutic interventions.
Contact
Naomi Asantewa-Sechereh;     Phone: [+442074512515];     Email: kavli.events@royalsociety.org
Topics
redox signalling, Reactive oxygen species (ROS), oxidative damage, mitochondria, mitochondrial therapies
Related subject(s)
38.
 
14th Annual Pharma IT Congress
ID
787558
Dates
28 Sep 2016 - 29 Sep 2016
Location
London, United Kingdom
Abstract
Oxford Global are proud to present the 14th Annual Pharmaceutical IT Congress, taking place on 28 – 29 September 2016 in London, UK. This highly established event will focus on exciting Big Data implementation case studies, novel research results in translational informatics, updates in data management for Real-World Evidence and novel IT solutions. The pharmaceutical IT industry represents a complex area of research that is under continuous pressure to develop novel solutions to improve its performance. Thanks to recent advancements in cloud computing solutions, Real-World Data and analytics, the industry is flourishing.
Contact
Guillaume Alonso;     Phone: [+44 (0)1865 248 455];     Email: g.alonso@oxfordglobal.co.uk
Topics
Over 200 delegates representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions Over 40 presentations and case studies focusing on the key developments in Big Data, Translational Informatics, Data Management for Real-World Evidence and IT Solutions Including 4 interactive streams: - Utilising Big Data In R&D - Translational Informatics - Data Management For Real-World Evidence - Novel IT Solutions
Related subject(s)
39.
 
ICONAN 2016 — International Conference On Nanomedicine And Nanobiotechnology
ID
785156
Dates
28 Sep 2016 - 30 Sep 2016
Location
Paris, France
Abstract
The target is to set up one of the most attractive international annual gatherings of experts from all around the world, in order for them to exchange about their latest research results and share their ideas.
Contact
ICONAN 2016 Organizing Committee;     Phone: [0033781201182];     Email: iconan2016@premc.org
Topics
Targeted drug delivery and nanocarriers, Nanomedicine for cancer diagnosis & therapy, Biological & medical nanodevices and biosensors, Tissue engineering and regenerative nanomedicine, Toxicology and risk assessment of nanomedicine systems, Nano-Imaging for diagnosis, therapy and delivery, Bionanocatalysis and nanobisystems, Microfluidics in nanomedicine and nanobiology.
Related subject(s)
40.
 
Biosimilars Europe
ID
809608
Dates
29 Sep 2016 - 30 Sep 2016
Location
London, United Kingdom
Abstract
SMi Group is thrilled to present the 7th annual conference, Biosimilars Europe , taking place on 29th & 30th September 2016 in Central London, UK. Gathering an audience of principle scientists and regulatory experts involved in biotechnology and compliance, Biosimilars Europe 2016 will provide a perfect platform to discuss global market developments and strategies to market access. Created with a top panel of industry thought leaders, this year's event will capture expert insight by honing in on the biosimilar product life-cycle from early stage developments, protein characterisation, and pricing & reimbursement; through to emerging markets and global developments. Join us this autumn to arm yourself with the key requirements and tools for successful market entry through strategic direction on commercialisation; insight into potential therapeutic areas; and guidance on product quality assessment (PQA) in biosimilar development. The notable speaker line-up includes: Boehringer Ingelhei, Merck, Lupin Ltd, Bristows, Austrian Agency for Health and Food Safety + many more!
Contact
Teri Arri;     Phone: [+442078276000];     Email: tarri@smi-online.co.uk
Topics
biosimilars, biobetters, conference, regulatory, patent, us market, generics, pricing and reimbursement, market access, commercialisation, EU, global developments, emerging markets, pharmacovigilance, protein characterisation, analytical comparability, approval, immunogenicity, pqa, product quality assessment, comparative analysis, pricing and reimbursement, p&r, litigation, , European regulation, biogenerics, IP, intellectual property, data protection, supplementary protection certificate, payer
41.
 
ADDCIn16 — Antibodies and Antibody Drug Conjugates
ID
812350
Dates
29 Sep 2016 - 30 Sep 2016
Location
Bengaluru, India
Abstract
SELECTBIO brings to you its 2nd International conference on ADC Development & Manufacture
Contact
SelectBio India;     Phone: [7696225050];     Email: sb.jatinkashyap@gmail.com
Topics
ADC Development - Issues and Challenges, Antibody Engineering for ADCs, Bioanalytical Strategies for ADCs, Novel Conjugation Technologies, Payload & Linkers, Strategies Development of Specific and Targeted ADCs.
42.
 
DDindia16 — Drug Discovery India 2016
ID
812404
Dates
29 Sep 2016 - 30 Sep 2016
Location
Bengaluru, India
Abstract
SELECTBIO is delighted to announce its 4th International Drug Discovery India 2016 Conference and Exhibition. This conference will be held in Hotel Fairfield by Marriott, Bengaluru on September 29-30, 2016. The theme of the conference is
Contact
SelectBio India;     Phone: [7696225050];     Email: sb.jatinkashyap@gmail.com
Topics
Drug Discovery India
43.
 
ComplianceOnline Pharma Summit 2016 – Risk Control and Compliance
ID
819521
Dates
06 Oct 2016 - 07 Oct 2016
Location
Philadelphia, United States
Abstract
Pharmaceutical and biotechnology companies across the globe face unprecedented challenges in the dynamically changing clinical, regulatory and business landscape. Aging populations, chronic diseases, technology and treatment advances are expected to spur health sector growth in 2016. As we approach 2016, it is imperative that leaders in the pharma space understand the trends and shifts happening around them.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
Pharma Summit 2016 - Risk control & Compliance, Biopharma summit 2016, Pharma Conferences, Pharma Events, Biotech Pharma Conclave
44.
 
European Pharmaceutical Market Access and Pricing & Reimbursement
ID
809066
Dates
10 Oct 2016 - 11 Oct 2016
Location
London, United Kingdom
Abstract
SMi Group’s 22nd annual European Pharmaceutical Market Access, Pricing and Reimbursement conference returns to London from 10-11 October 2016. The conference is one of the most established in the world, focusing on the changes in pricing and reimbursement and market access. Learn about new strategies, their strengths, weaknesses and future implications.
Contact
Fateja Begum;     Phone: [+44 (0) 20 7827 6184];     Email: fbegum@smi-online.co.uk
Topics
pricing, market access, reimbursement, medicine, regulation, pharmacology,
45.
 
World ADC — World ADC San Diego
ID
803096
Dates
10 Oct 2016 - 13 Oct 2016
Location
San Diego, United States
Abstract
Now in it’s 7th year, World ADC San Diego is the industry’s most definitive antibody drug conjugate forum. Its mission is to enable drug developers to realize the next generation of clinically successful ADC drugs. 
Contact
Jenny Barlow;     Phone: [+1 212 537 5898];     Email: info@hansonwade.com
Topics
Develop Next Generation Clinically Transformative ADCs 2016 is set to be a momentous year for antibody-drug conjugates. Since the start of 2016 alone 3 new ADCs have entered human testing, joining the 54 ADCs already in clinical trials. The ADC industry is on the cusp of realizing the next therapeutic breakthrough. Rapidly diversifying payload, linker and antibody technologies and a surge of novel preclinical ADCs powering towards the clinic have all contributed to this gaining of momentum. Now in it’s 7th year, World ADC San Diego is the industry’s most definitive antibody drug conjugate forum. Its mission is to enable drug developers to realize the next generation of clinically successful ADC drugs. Covering the A-Z of ADCs, World ADC San Diego strikes the balance between distilling ground-breaking science with transformative research that will empower your programs tomorrow. This year, 650 prominent minds from 190 organisations will descend on World ADC San Diego giving you an unparalleled opportunity to foster new connections, catch-up with peers and progress business partnerships.
Event website
46.
 
The Structure of Clinical Trials and Experimental Therapeutics - University of Oxford
ID
749593
Dates
10 Oct 2016 - 14 Oct 2016
Location
Oxford, United Kingdom
Contact
Course Administrator;     Phone: [01865 286955];     Email: expther@conted.ox.ac.uk
Topics
pharmacology, drug development, clinical trials, experimental therapeutics, oxford
47.
 
Pharma Expo
ID
800871
Dates
12 Oct 2016 - 14 Oct 2016
Location
Saint-Petersburg, Russia
Abstract
The 4th International exhibition of medicines, nutritional and dietary supplements Pharma will take place on 12-14 October 2016 in CEC EXPOFORUM in St. Petersburg.  International Exhibition of medicines, food and dietary supplements Pharma is important industry events for professionals in the medicine and pharmaceutical industry in the Northwest Russia.  The exhibition will be held as part of the St Petersburg International Health Forum.
Event website
48.
 
Training — Diabetes: An Overview
ID
791265
Start date
13 Oct 2016
Location
London, United Kingdom
Abstract
This introductory course provides an overview of the causes, mechanisms and management of diabetes from both a clinical management and a drug development perspective. Our expert speaker will introduce the pathogenesis of the disease and discuss current prevention and treatment options as well as the complications associated with diabetes. The complex inter-relationship with dyslipidaemias, hypertension, obesity and subsequent cardiovascular risk will be examined in some detail.
Contact
Linda Merritt;     Phone: [01727 809917];     Email: courses@healthcare-ed.com
Topics
Clinical presentation and classification, Pathophysiology of T2 diabetes, Treatment options, Micro and macrovascular complications, Prevention of type 2 diabetes – the evidence
49.
 
International Paediatric Pharmaceutical Care Masterclass
ID
800014
Dates
13 Oct 2016 - 15 Oct 2016
Location
London, United Kingdom
Abstract
This is a highly practical masterclass designed by the expert pharmaceutical team at Evelina Children’s Hospital London, part of Guy’s and St Thomas’ NHS Foundation Trust. The masterclass combines case studies, lectures, role plays and patient case reviews at hospital bed sides.
Related subject(s)
50.
 
GCC Pharmacy Congress
ID
773490
Dates
17 Oct 2016 - 20 Oct 2016
Location
Dubai, United Arab Emirates
Abstract
As the GCC countries healthcare moves towards a more patient-centric model, pharmacists are playing an increasingly important role in providing quality care to patients and they are vital members of the healthcare team. Pharmacists play an important role as leaders to improve healthcare outcomes, decrease cost, reduce patient safety risk, optimise medication management systems and align the pharmacy services with the management strategies that measure and reward quality performance. However, the continuing evolution of pharmacist role is tied to numerous challenges including collaboration with the different stakeholders in the medical community, learning about new technologies, remaining competitive in the marketplace, improving patient outcomes, maintaining productivity and more.
51.
 
WTCRF: Using Mixed Methods in Research
ID
807620
Start date
19 Oct 2016
Location
Edinburgh, United Kingdom
Abstract
Through a mixture of lectures and workshops, this one-day course will: - Discuss the long-standing “dichotomy” between quantitative and qualitative methods, and explore how these can be compatible when conducting mixed methods research - Explore the relevance of mixed methods designs for healthcare research and complex interventions - Explore the rationale behind “mixing” methods - Present the key taxonomies of mixed methods designs - Explore the epistemological underpinnings of mixed methods designs (pragmatism) - Provide a wider content for mixed methods research and link this to the Medical Research Council (MRC) Framework, and the principles of Implementation Science - Discuss the practicalities of designing and conducting mixed methods research as well as presenting related findings Date: Wednesday 19th October 2016 Time: 0930-1630 Venue: Seminar Room, Wellcome Trust Clinical research Facility, Western General Hospital, Edinburgh Course Fees: Student Rate: (valid matriculation card required) �40 NHS/Uni Early Bird Rate: (before 31 Aug 2016) �60 NHS/Uni Rate: (after 31 Aug 2016) �80 Industry: �160 For more information, or to book a place, please visit the WTCRF website www.crts.org.uk or contact us at wtcrf.education@ed.ac.uk or 44 (0)131 357 3355 Facebook: https://www.facebook.com/WTCRFEducationProgramme Twitter: @WTCRF_Education
Related subject(s)
52.
 
RareX — RareX Rare Diseases Conference ft. ICORD
ID
803542
Dates
19 Oct 2016 - 22 Oct 2016
Location
Cape Town, South Africa
Abstract
The purpose of this conference is to provide a global forum for all stakeholders within the Rare Disease field, both locally and abroad, to participate in open discussion, enhance models of best practice and share specialist knowledge around rare diseases and orphan drugs. Incorporating the annual International Conference on Rare Diseases and Orphan Drugs (ICORD) for 2016, RareX has an extended program, to incorporate patients, their families and caregivers as well as support groups and minority groups within the rare disease community.
Contact
Renee;     Phone: [+27 (0) 21 683 2934];     Email: info@rarex.co.za
Topics
Rare Diseases, RareX, Orphan Drugs, Orphan diseases, ICORD, Rare Diseases South Africa
Related subject(s)
Event website
53.
 
2nd Antibody Drug Conjugates Conference
ID
820075
Dates
24 Oct 2016 - 25 Oct 2016
Location
Boston, United States
Abstract
We invite you to attend the 2nd Antibody Drug Conjugates Conference, which will take place October 24-25, 2016 in Boston, MA. This event will bring together an exciting balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and gain a fresh perspective on the emergence of recent data from ADC clinical trials, new linkers and payloads, personalized healthcare, site specific attachment, and ADC therapeutics. With the field of antibody drug conjugates rapidly expanding and the increasing number of ADC clinical trials, novel therapeutics are emerging. The ADC therapeutic area combines synthetic chemistry with rationale biology and is advancing monoclonal antibody treatments into the realm of precision medicine with improved effectiveness and therapeutic indices.
54.
 
7th Euro-Global Summit on Toxicology and Applied Pharmacology
ID
804860
Dates
24 Oct 2016 - 26 Oct 2016
Location
Rome, Italy
Abstract
Euro Toxicology 2016 enables the participants to “Connect, Collaborate and Perceive the Cutting Edge Research Works.” Eurotox aims to foster the spread of the newest advancements in the field of Toxicology and Pharmacology. It bestows a proficient platform to the students to traverse through the top notch research works by the leaders in the field.
Contact
Valentina Leyva;     Phone: [702-508-5197];     Email: valentinaleyva10@gmail.com
Topics
toxicology, pharmacology, euro toxicology 2016, eurotox, pathology, toxicology conference in Europe, genetics, genetic toxicology, toxicity, clinical toxicology, poison, experimental toxicology, clinical toxicologists
55.
 
4th Antibody & Protein Therapeutics Conference
ID
820043
Dates
25 Oct 2016 - 26 Oct 2016
Location
Boston, United States
Abstract
We welcome you to the 4th Antibody & Protein Therapeutics Conference, which will be held October 25-26, 2016 in Boston, MA. This conference strives to connect industry and academic researchers in the protein therapeutics field to facilitate discussion on the current state of the industry and discuss recent studies and challenges involved in therapeutic development.
56.
 
IMN — 8th Annual Immunogenicity and Bioassay Summit
ID
811196
Dates
26 Oct 2016 - 28 Oct 2016
Location
Baltimore, MD, United States
Abstract
Following year-on-year success, CHI presents the Eighth Annual Immunogenicity and Bioassay Summit 2016: 3 conferences, FDA presenters plus 40+ additional presentations, 15+ interactive breakout round table and panel discussions, short courses, exhibit/poster hall, and networking opportunities with 250+ delegates. Immunogenicity Prediction & Control is designed to help investigators design and select non-immunogenic products for early-stage decision making, while Immunogenicity Assessment & Clinical Relevance and Optimizing Bioassays for Biologics will enable investigators to overcome the complexities of immunogenicity assessment and bioassays, and develop programs that ensure their products are safe and efficacious, and satisfy regulatory requirements.
Contact
Phone: [781-972-5400];     Email: chi@healthtech.com
Topics
Immunogenicity, Clinical Relevance, Bioassays, Biologics
57.
 
Keystone Symposia: Translational Vaccinology for Global Health
ID
806823
Dates
26 Oct 2016 - 30 Oct 2016
Location
London, United Kingdom
Abstract
The time required to launch new global health vaccines is too long and the late failure rate is unsustainably high. Key barriers include insufficient diversity and quality of preclinical concepts and candidates, immunobiological ignorance, and a lack of understanding of correlates or mechanisms of protection. Root causes include siloed science and linear thinking; poor integration across the discovery/development/delivery ecosystem; and slow entry and limited throughput in early human proof of concept testing. This Keystone Symposia meeting aims to bring together those pioneering novel, creative solutions to these problems of global vaccine discovery and development across the academic/biotech/product development partner/pharma spectrum.
Contact
Attendee Services;     Phone: [1+ 970-262-1230 or 800-253-0685];     Email: info@keystonesymposia.org
Topics
Vaccines Immunology Infectious Diseases Global Health
Related subject(s)
58.
 
Training — Immunotherapies: An Introductory Overview
ID
791296
Start date
03 Nov 2016
Location
London, United Kingdom
Abstract
This one-day programme provides an introduction to immunotherapies. Immunotherapies are an increasingly important treatment method for a wide range of diseases. This training is developed specifically for pharmaceutical industry personnel and provides a thorough foundation to the subject applicable across therapy areas. It is ideal for individuals with little understanding of immunotherapies and equally beneficial to those with existing basic knowledge enabling further insight to the subject through detailed presentations and discussion with Healthcare’s expert physician faculty.
Contact
Linda Merritt;     Phone: [01727 809917];     Email: courses@healthcare-ed.com
Topics
The immune system – a guide, Introduction to immunotherapies, What goes wrong!, Examples in practice, The future
59.
 
BIO-Europe® 2016 - 22nd Annual International Partnering Conference
ID
796044
Dates
07 Nov 2016 - 09 Nov 2016
Location
Cologne, Germany
Abstract
BIO-Europe® is the preeminent partnering conference for the life sciences, bringing together international decision makers from the biotechnology, pharmaceutical and financial sectors, offering networking opportunities, workshop and panel participation, a high profile exhibition, and private, prescheduled one-to-one meetings.
Contact
Catharine Moreno Finan;     Phone: [+49 89 2388 756-25];     Email: cmoreno@ebdgroup.com
Topics
partnering, business development, biotech, pharmaceutical, medical device, diagnostic, licensing, finance, life science
Related subject(s)
60.
 
E&L Europe 2016 — Extractables & Leachables Europe 2016
ID
808762
Dates
08 Nov 2016 - 10 Nov 2016
Location
Dublin, Ireland
Abstract
The Smithers Rapra Extractables & Leachables conferences, held in both the US and in Europe, are the only two of their kind. Both events deliver a cutting edge analysis of testing techniques and high level insight into the global regulatory landscape, while allowing extensive time for debate and networking.
Contact
Emma Newton;     Phone: [+44 (0) 1372 802016];     Email: enewton@smithers.com
Topics
extractable, leachable, pharmaceutical, packaging, pharmaceutical testing, medical devices, e-cigarettes, packaging testing, mass-spectrometry
61.
 
Gynaecological Oncology — An Update on Topical Issues within Gynaecology Oncology
ID
805575
Start date
09 Nov 2016
Location
South Kensington, London, United Kingdom
Contact
Conference Team;     Phone: [020 7808 2921 / 4];     Email: conferenceteam@rmh.nhs.uk
Topics
Update in Gynaecology Oncology Surgery, Long term GI effects of cancer treatment; Genetics and BRCA testing in Gynaecology Oncology; Update in Gynaecology Clinical Oncology and Nurse led Clinics in Endometrial cancer, A Patient’s perspective, Supporting Women on aspects of motherhood and parenting, Update in Gynaecology Medical Oncology and Nurse led Chemotherapy Clinics, Sexuality post treatment for Gynaecological cancers, Summary and questions session.
Related subject(s)
62.
 
WPE — Inaugural World Preclinical Congress Europe
ID
820621
Dates
14 Nov 2016 - 16 Nov 2016
Location
Lisbon, Portugal
Abstract
The World Preclinical Congress Europe is a key networking event bringing together a global audience involved in preclinical research. It features conferences and short courses that cover the very latest in preclinical strategies and technologies, to enable better and faster decisions in drug discovery. With the broad range of conference's covered, the event offers a diverse cross-disciplinary environment for tackling translational challenges and sharing best practices. It’s where preclinical minds meet discovery technologies to innovate traditional drug discovery by sharing ideas, showcasing new technologies, and fostering new collaborations.
Contact
Phone: [7819725400];     Email: chi@healthtech.com
Topics
medicinal chemistry, lead optimization, drug toxicity, preclinical research, cancer immunotherapy, CRISPR, drug discovery
63.
 
APAMT2016 — Asia Pacific Association of Medical Toxicology 15th Scientific Congress
ID
788226
Dates
17 Nov 2016 - 20 Nov 2016
Location
Singapore, Singapore
Abstract
The Toxicology Society of Singapore warmly invites all of you to join us in the 15th International Scientific Conference of the Asia Pacific Medical Association of Medical Toxicology (APAMT) 2016. This will be the first time that the APAMT conference is held in Singapore. APAMT 2016 promises an exciting experience as we bring together Clinical Toxicologists, Specialists in Poisons Information and researchers and scientists from all over the world, especially from the Asia Pacific to discuss their research, share experience and make new friends. The theme for this conference is “A Toxicologist’s Rendezvous – Meeting of the Disciplines”.

We look forward to welcoming you in Singapore in 2016!

Contact
Conference Secretariat;     Phone: [+65 6570 6280];     Email: info@apamt2016.com
Topics
Toxicology Poison Analysis Chemical Environmental Toxinology
64.
 
International Congress on Immunology and Vaccine Research
ID
817944
Dates
28 Nov 2016 - 30 Nov 2016
Location
Dubai, United Arab Emirates
Abstract
Immuno congress - 2016 is organized in association with Journal of Immunological Diseases, Disorders and their Prevention, an open access and peer reviewed journal that publishes articles in the field of experimental, clinical immunology, host defense, autoimmune disorders and other related topics. Immunology is a branch of biomedical science that covers the study of all dimensions of immunology. The immunology journal aims in covering the recent technologies and findings in the field of medical science.
Contact
Dhwani Hissaria;     Phone: [1-646-202-2876];     Email: immunocongress2016@clytoaccess.com
Related subject(s)
65.
 
28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
ID
773640
Dates
28 Nov 2016 - 02 Dec 2016
Location
Munich, Germany
Abstract
It is our great pleasure to announce that the   28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics   will take place in Munich.  Hosted by the European Organisation for Research and Treatment of Cancer (EORTC), the National Cancer Institute (NCI) and the American Association for Cancer Research (AACR), the 2016 Symposium will bring together around 2000 academics, scientists and pharmaceutical industry representatives from across the globe to discuss innovations in drug development, target selection and the impact of new discoveries in molecular biology. As a one-of-a-kind Symposium at the forefront of drug development, it will enable participants to apply the latest findings and knowledge in their work and practice. This edition will also build on the success of the previous symposium which was widely praised for the quality of its programme, inspirational contributions and exclusive insights.
Related subject(s)
66.
 
6th Munich Biomarker Conference - Clinical Practice and Targeted Therapies in Personalized Medicine
ID
789603
Dates
29 Nov 2016 - 30 Nov 2016
Location
Munich, Germany
Abstract
We believe that the challenges of future medicine can only be solved by an interdisciplinary approach. On the one hand, biomarker-driven drug development follows common strategies, on the other hand, only joint efforts will transform the health care system. Therefore, the 6th Munich Biomarker Conference is open to various indications, including, but not limited to, oncology, respiratory diseases, immunology and infection, neurological disorders and orphan diseases.
Contact
BioM Biotech Cluster Development GmbH;     Phone: [+49 (0) 89 / 89 96 79-0];     Email: info@bio-m.org
Topics
Biomarker discovery, validation and clinical use, biomarkers in drug discovery and development, innovative biomarker, technologies, cell-based and cell-free assays, liquid biopsy, biomarkers for immunotherapy, personalized medicine, companion diagnostics and patient selection, combination therapies, patient monitoring, evidence-based medicine
Event website
67.
 
MPMC — MENA Pharmaceutical Manufacturing Congress
ID
802885
Dates
29 Nov 2016 - 01 Dec 2016
Location
Jeddah, Saudi Arabia
Abstract
The MENA Pharmaceutical Manufacturing Congress, will set a unique platform by gathering the pioneers of local and international pharmaceutical companies; CEOs, plant managers, production managers, supply chain managers, quality assurance managers, regulators affairs managers, and engineers. In addition to the leading technology providers who will showcase the latest technologies and developments in pharmaceutical manufacturing. The congress will include case studies, presentations, and interactive panel discussions which will focus on issues such as the obstacles fronting the pharmaceutical industry, the integration between the different concerned entities, and the future of the industry in the region. The conference will also be accompanied by an exhibition that features the latest machinery and technologies used during the different pharmaceutical manufacturing stages, raw materials suppliers, and the regional manufacturers in the country. Join the MENA Pharmaceutical Manufacturing Congress, to gain knowledge and learn about the innovative strategies which are driving the growth of the pharmaceutical manufacturing in the MENA region, and leading the industry towards excellence.
Contact
Yarina;     Phone: [+971 4 361 9616];     Email: info@pharmamanufacturingmena.com
Topics
Pharmaceutical, Manufacturing, Drug, MENA
68.
 
PharmaMed-2016 — International Conference on Medicinal and Pharmaceutical Chemistry
ID
812407
Dates
05 Dec 2016 - 07 Dec 2016
Location
Dubai, United Arab Emirates
Abstract
International Conference on Medicinal and Pharmaceutical Chemistry is going to be held during December 5-7, 2016 at Crowne Plaza, Dubai, UAE. This scientific conference bring upon a new platform to share and discuss all the innovations in the Medicinal and Pharmaceutical Chemistry.
Contact
James Martin;     Phone: [+1-302-231-6959];     Email: pharmamed@madridge.com
Topics
Molecular Modeling and Computer-Aided Drug Design, Drug Discovery from Synthetic and Natural Sources, Drug Design and Drug Delivery, Biopharmaceutics, Chemical Biology and Biophysics, Pharmacology, Toxicology and Pharmacogenomics, Pharmacodynamics and Pharmacokinetics, Pharmaceutical Analysis: Analytical Methods, Pharmaceutical Market, Antibiotics and Anti Cancer Drugs, Advances in Drug Discovery and Medicinal Chemistry, Pharmacology Applications in Medicine.
69.
 
Vaccines-2017 — International Conference on Vaccines-2017
ID
811338
Dates
20 Feb 2017 - 22 Feb 2017
Location
Baltimore, United States
Abstract
This scientific conference will bring an opportunity to share potential benefits and limitations of vaccines in preventing and control of infectious and non-infectious diseases thereby enhancing the quality and longevity of life.Vaccines 2017 mainly showcases comprehensive approaches in Vaccines and research, virology. vaccine conference includes Plenary lectures, Keynote lectures and short courses by eminent personalities from around the world in addition to contributed papers both oral and poster presentations
Contact
James Martin;     Phone: [1-302-231-6959];     Email: Vaccines@madrige.com
Topics
Vaccines, virology, Infectious and non infectious diseases, Therapeutic Medicines
70.
 
MESMAP-3 — The Third Mediterranean Symposium on Medicinal and Aromatic Plants
ID
811581
Dates
13 Apr 2017 - 16 Apr 2017
Location
Girne (Kyrenia), Cyprus, Turkey
Related subject(s)
Event website
71.
 
Antibodies & Complement: Effector Functions, Therapies & Technologies
ID
781835
Dates
20 Jun 2017 - 23 Jun 2017
Location
Albufeira, Portugal
Abstract
The antibody response and the complement system are major effector arms of the immune system. Both have been involved in a plethora of pathological conditions – including autoimmunity, allergy, infections and cancer- and regulate, mainly through their receptors (FcR and CR respectively) cell activation, migration, survival but also metabolism. As the portfolio of antibody- and complement-effector function grow, high-end technological solutions are developed and novel therapeutic applications are proposed.

This Zing conference will focus attention on key advances in both fields with the aim at fostering discussions between antibody experts and complement experts.

Related subject(s)

Good to know...

You can advertise your event or services in this space.

Last updated: 30 October 2092